Leading Pharma recalls
FDA enforcement reports naming Leading Pharma, LLC as the recalling firm.
- Recall reports
- 3
- Class I (serious)
- 0
- Most recent report
- Apr 29, 2026
- Apr 29, 2026Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading…Drug · Leading Pharma, LLCCGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.Class II
- Oct 5, 2022ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHAR…Drug · Leading Pharma, LLCSuperpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsulesClass III
- Nov 29, 2017Lorazepam Tablets, USP CIV, 0Drug · Leading Pharma, LLCLabeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepamClass II